Novel combinations are emerging
Footnotes This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed
Now, when were seeing GLP-1s, it is really important to say, Can this actually make a difference? If I were to objectively utilize this and am able to say, I have someone who has sleep apnea, I have someone who has insomnia, I have someone who has another sleep disorder, do we see any meaningful change
This holds across all three commitment tiers, ensuring predictable costs as your provider adjusts your therapy over time
The newer treatments include Wegovy, a slightly higher dose of Novo Nordisks diabetes drug Ozempic, and Mounjaro, an Eli Lilly diabetes treatment for which the company is currently seeking FDA approval as a weight-loss drug